Biohaven Pharmaceutical H...

AI Score

XX

Unlock

24.05
-3.60 (-13.02%)
At close: Mar 31, 2025, 2:23 PM
25.26
4.99%
After-hours: Mar 31, 2025, 05:43 PM EDT

Biohaven Pharmaceutical Ltd. Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY17
Revenue n/a n/a n/a 462.51M n/a n/a n/a
Cost of Revenue n/a 3.37M 1.39M 91.66M 72K n/a n/a
Gross Profit n/a -3.37M -1.39M 370.85M -72K n/a n/a
Operating Income -885.11M -436.05M -567.93M -218.9M -114.51M -479.12M n/a
Interest Income n/a 17.73M n/a n/a n/a n/a n/a
Pretax Income -845.69M -409.55M -569.84M -212.43M -118.67M -528.39M n/a
Net Income -846.42M -408.17M -570.28M -213.8M -118.67M -528.8M n/a
Selling & General & Admin 89.24M 62.77M 130.86M 37.41M 16.05M 134.45M n/a
Research & Development 795.87M 373.28M 437.07M 181.49M 98.46M 344.67M n/a
Other Expenses n/a n/a -1.91M 1.21M n/a n/a n/a
Operating Expenses 885.11M 436.05M 567.93M 218.9M 114.51M 479.12M n/a
Interest Expense n/a n/a n/a n/a n/a -12.71M n/a
Selling & Marketing Expenses n/a 5.87M n/a n/a n/a n/a n/a
Cost & Expenses n/a 436.05M 567.93M 218.9M 114.51M 479.12M n/a
Income Tax 735K -1.38M 438K 1.37M -134.3K 419K n/a
Shares Outstanding (Basic) 91.23M 71.2M 44.74M 35.82M 35.82M 48.49M n/a
Shares Outstanding (Diluted) 91.23M 71.2M 44.74M 35.82M 35.82M 48.49M n/a
EPS (Basic) -9.28 -5.73 -12.75 -5.97 -3.31 -10.91 n/a
EPS (Diluted) -9.28 -5.73 -12.75 -5.97 -3.31 -10.91 n/a
EBITDA -885.11M -429.14M -462.8M -217.51M -114.43M -479.12M n/a
Depreciation & Amortization n/a 6.91M 1.39M 1.39M 72K 171.86K 52.52K